MedPath

Efficacy of probiotics adjuvant therapy of allergic rhinitis

Phase 4
Recruiting
Conditions
efficacy of probiotics in treatment of allergic rhinitis
allergic rhinitis,rhinitis,probiotics,efficacy
Registration Number
TCTR20240528002
Lead Sponsor
HRH princess Maha Chakri Siridhorn Medical center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
104
Inclusion Criteria

1. Age 18-60 years
2. Confirm diagnosis of allergic rhinitis

Exclusion Criteria

1.chronic rhinosinusitis with or without nasal polyp
2.nasal mass or nasal cancer or sinus cancer
3.petient with adverse effect of probiotics
4.pregnancy or lactating woman
4.caution with probiotic e.g.immunocompromise, prosthetic heart valves, impaired intestine function, central venous catheter, jejunostomy, broad-spectrum antimicrobials and poorly control diabetes mellitus

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
to study the efficacy of probiotics in treatment allergic rhinitis comparison with placebo controlled 8 weeks using Visual analogue scale (VAS) , Rhinitis control assessment test (RCAT),and Total nasal symptom score (TNSS)
Secondary Outcome Measures
NameTimeMethod
Comparison the quality of life and side effect of probiotics in treatment allergic rhinitis 8 weeks Using rhinoconjunctivitis quality of life questionaire (RQLO)
© Copyright 2025. All Rights Reserved by MedPath